Sarah E. Perry

Sarah E. Perry

Auto-generated profile, based on publicly available information

Sarah E. Perry

New Zealand Brain Research Institute, Christchurch

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2019 in Journal of Oral Rehabilitation
Verified
Journal Article
Closed access
PDF file
SPSarah E. Perry
Sarah E. Perry
MHMaggie‐Lee Huckabee
Maggie‐Lee Huckabee
GTGeoffrey Tompkins
Geoffrey Tompkins
TMTrudy J. Milne
Trudy J. Milne

7 March 2024 in American Journal of Speech-Language Pathology
Verified
Journal Article
Closed access
SPSarah E. Perry
Sarah E. Perry
MTMichelle Troche
Michelle Troche
JHJessica E. Huber
Jessica E. Huber
JCJames Curtis
James Curtis
BKBrianna Kiefer
Brianna Kiefer
DBDeanna Britton
Deanna Britton
Purpose: This systematic review represents an update to previous reviews of the literature addressing behavioral management of respiratory/phonatory dysfunction in individuals with dysarthria due to neurodegenerative disease. Method: Multiple electronic database searches and hand searches of prominent speech-language pathology journals were conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. Results: The search yielded 1,525 articles, from which 88 met inclusion criteria and were reviewed by two blinded co-investigators. A large range of therapeutic approaches have been added to the evidence base since the last review, including expiratory muscle strength training, singing, and computer- and device-driven programs, as well as a variety of treatment modalities, including teletherapy. Evidence for treatment in several different population groups—including cerebellar ataxia, myotonic dystrophy, autosomal recessive spastic ataxia of Charlevoix–Saguenay, Huntington's disease, multiple system atrophy, and Lewy body dementia—were added to the current review. Synthesis of evidence quality provided strong evidence in support of only one behavioral intervention: Lee Silverman Voice Treatment Program (LSVT LOUD) in people with Parkinson's disease. No other treatment approach or population included in this review demonstrated more than limited evidence, reflecting that these approaches/populations require urgent further examination. Conclusion: Suggestions about where future research efforts could be significantly strengthened and how clinicians can apply research findings to their practice are provided. Supplemental Material: https://doi.org/10.23641/asha.24964473

15 May 2021 in Dysphagia
Verified
Journal Article
Closed access
PDF file
SPSarah E. Perry
Sarah E. Perry
JBJames C. Borders
James C. Borders
ADAvery E. Dakin
Avery E. Dakin
MTMichelle S. Troche
Michelle S. Troche

14 August 2022 in Journal of the Royal Society of New Zealand
Verified
Journal Article
Closed access
MMMichael R. MacAskill
Michael R. MacAskill
TPToni L. Pitcher
Toni L. Pitcher
TMTracy R. Melzer
Tracy R. Melzer
DMDaniel Myall
Daniel Myall
KHKyla‐Louise Horne
Kyla‐Louise Horne
TATim Anderson
Tim Anderson
We describe the New Zealand Parkinson's Progression Programme (NZP3), its goals, findings, and future plans. To date, 354 people with Parkinson's disease and 89 healthy older controls have participated over a 14‐year period. A major focus of the programme has been the characterisation of current cognitive impairment, and the identification of biomarkers for its future emergence in people with Parkinson's. The programme has made significant contributions to the concept of mild cognitive impairment (MCI) in Parkinson's and the development and validation of standardised criteria for it. Brain imaging, both MRI and PET, has also been a focus, showing associations between increasing brain pathology and declining cognitive function. Additional biomarkers such as genetics, fluid biomarkers, eye movement, speech, and quantitative electroencephalography (EEG) are also under investigation. The programme has become a platform supporting many other avenues of research, from investigating the personal impacts of caregiver burden through to national‐level epidemiology. To date, the programme has led to multiple journal publications and 17 completed and 9 ongoing PhDs, and many other postgraduate theses. It has led to the development of a skilled core of early‐career through to senior researchers and clinicians. We discuss the future directions for the programme.

2 January 2021 in Dysphagia
Verified
Journal Article
Closed access
PDF file
SPSarah E. Perry
Sarah E. Perry
MTMichelle S. Troche
Michelle S. Troche

10 July 2025 in American Journal of Speech-Language Pathology
Verified
Journal Article
Closed access
LGLauren Tabor Gray
Lauren Tabor Gray
SSSamantha Shune
Samantha Shune
SPSarah Perry
Sarah Perry
DKDerek Kosty
Derek Kosty
ANAshwini Namasivayam-MacDonald
Ashwini Namasivayam-MacDonald
Purpose: Providing care for family members with neurodegenerative diseases entails significant physical and psychosocial costs, increasing caregiver burden. Limited research exists on the factors contributing to dysphagia-related burden, particularly across disease trajectories. This study aimed to (a) determine if dysphagia-related burden predicts general caregiver burden, (b) identify predictors of dysphagia-related burden, and (c) examine relationships between dysphagia severity, disease severity, and dysphagia-related burden. Method: Care partners ( N = 211; 80% female; M age = 60 ± 14 years) from clinics in Canada, New Zealand, and the United States participated. Care recipients included those with amyotrophic lateral sclerosis (ALS; n = 48), dementia ( n = 110), and Parkinson's disease (PD; n = 53). General burden was measured using the Zarit Burden Interview, while dysphagia-related burden was assessed via the Caregiver Assessment of Reported Experiences with Swallowing Difficulties. Multiple regression analyses examined predictors of general and dysphagia-related burden and their relationships to dysphagia and disease severity. Results: Higher general burden was associated with female caregivers (β = −.19, p = .05), higher education (β = .16, p = .03), caring for someone with dementia (β = .36, p = .01), and greater dysphagia-related burden (β = .33, p = .01). Predictors of dysphagia-related burden included working caregivers (β = .15, p = .01), increased dysphagia symptoms (β = .77, p < .01), and caring for individuals with ALS or dementia (vs. PD; β = −.16, p = .02). Dysphagia burden varied by disease severity and diet tolerance ( p < .01). Conclusions: Managing dysphagia independently contributes to caregiver burden, potentially increasing burnout and nonadherence to clinical recommendations. Early, proactive inquiry about dysphagia-related care partner burden and provision of support to minimize burden should be considered early in disease management. Supplemental Material: https://doi.org/10.23641/asha.28843055